| 标题 |
Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Klara R Klein; Carol Wysham; Katherine R Tuttle; Melanie J Davies; David Cox; et al 出版日期:2026-09-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)